Patent Assignment
Reel/Frame 035193/0855
Assignment of Assignor's Interest
Recorded: 2015-03-18
Pages: 5
Assignors
LOIBNER, HANS
Executed: 2015-02-23
SCHUSTER, MANFRED
Executed: 2015-02-12
JANZEK-HAWLAT, EVELYNE
Executed: 2015-02-23
WIEDERKUM, SUSANNE
Executed: 2015-02-12
PEBALL, BERNHARD
Executed: 2015-02-12
STRANNER, STEFAN
Executed: 2015-02-12
MUTSCHLECHNER, OLIVER
Executed: 2015-02-12
GROISS, FRANZ
Executed: 2015-02-23
LADENSTEIN, RUTH
Executed: 2015-02-23
LODE, HOLDER
Executed: 2015-02-23
Assignee
APEIRON BIOLOGICS AG
CAMPUS-VIENNA-BIOCENTER 5, VIENNA, 1030, AUSTRIA
Covered Property
(1)
Method for Treating a GD2 Positive Cancer
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 035193 Frame 0855. Assignor(S) Hereby Confirms the Assignment.
Jul 29, 2016
From: LOIBNER, HANS; SCHUSTER, MANFRED; JANZEK-HAWLAT, EVELYNE; WIEDERKUM, SUSANNE
To: APEIRON BIOLOGICS AG
Reel/Frame 039507/0472 →
License
Sep 18, 2017
From: APEIRON BIOLOGICS AG
To: EUSA PHARMA (UK) LIMITED
Reel/Frame 043882/0511 →
Change of Name
Dec 10, 2024
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069584/0365 →
Security Interest
Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →